# Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia

> **NCT04732429** · PHASE2 · TERMINATED · sponsor: **HemoShear Therapeutics** · enrollment: 26 (actual)

## Conditions studied

- Methylmalonic Acidemia
- Propionic Acidemia

## Interventions

- **DRUG:** HST5040
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04732429
- **Lead sponsor:** HemoShear Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-15
- **Primary completion:** 2023-10-20
- **Final completion:** 2023-10-20
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** The decision to terminate the study was based on business considerations by the Sponsor.
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04732429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04732429, "Study of HST5040 in Subjects With Propionic or Methylmalonic Acidemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04732429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*